Loading...
Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol.
Sydes, Matthew R Spears, Melissa R Mason, Malcolm D Clarke, Noel W Dearnaley, David P de Bono, Johann S Attard, Gerhardt Chowdhury, Simon Cross, Bill Gillessen, Silke
Sydes, Matthew R
Spears, Melissa R
Mason, Malcolm D
Clarke, Noel W
Dearnaley, David P
de Bono, Johann S
Attard, Gerhardt
Chowdhury, Simon
Cross, Bill
Gillessen, Silke
Authors
Sydes, Matthew R
Spears, Melissa R
Mason, Malcolm D
Clarke, Noel W
Dearnaley, David P
de Bono, Johann S
Attard, Gerhardt
Chowdhury, Simon
Cross, Bill
Gillessen, Silke
Malik, Zaf
Jones, Rob
Parker, Chris
Ritchie, Alastair W S
Russell, J Martin
Millman, Robin
Matheson, David
Amos, Claire L.
Gilson, Clare
Birtle, Alison
Brock, Susannah
Capaldi, Lisa
Chakraborti, Prabir
Choudhury, Ananya
Evans, Linda
Ford, Daniel
Gale, Joanna
Gibbs, Stephanie
Gilbert, Duncan
Hughes, Robert
McLaren, Duncan
Lester, Jason
Nikapota, Ashok
O'Sullivan, Joe
Parikh, Omi
Peedell, Clive
Protheroe, Andrew
Rudman, Sarah M
Shaffer, Richard
Sheehan, Denise
Simms, Matthew
Srihari, Narayanan
Strebel, Räto
Sundar, Santhanam
Tolan, Shaun
Tsang, David
Varughese, Mohini
Wagstaff, John
Parmar, Mahesh K B
James, Nicholas D
Spears, Melissa R
Mason, Malcolm D
Clarke, Noel W
Dearnaley, David P
de Bono, Johann S
Attard, Gerhardt
Chowdhury, Simon
Cross, Bill
Gillessen, Silke
Malik, Zaf
Jones, Rob
Parker, Chris
Ritchie, Alastair W S
Russell, J Martin
Millman, Robin
Matheson, David
Amos, Claire L.
Gilson, Clare
Birtle, Alison
Brock, Susannah
Capaldi, Lisa
Chakraborti, Prabir
Choudhury, Ananya
Evans, Linda
Ford, Daniel
Gale, Joanna
Gibbs, Stephanie
Gilbert, Duncan
Hughes, Robert
McLaren, Duncan
Lester, Jason
Nikapota, Ashok
O'Sullivan, Joe
Parikh, Omi
Peedell, Clive
Protheroe, Andrew
Rudman, Sarah M
Shaffer, Richard
Sheehan, Denise
Simms, Matthew
Srihari, Narayanan
Strebel, Räto
Sundar, Santhanam
Tolan, Shaun
Tsang, David
Varughese, Mohini
Wagstaff, John
Parmar, Mahesh K B
James, Nicholas D
Editors
Other contributors
Affiliation
Epub Date
Issue Date
2018-02-26
Submitted date
Subjects
Alternative
Abstract
Adding abiraterone acetate with prednisolone (AAP) or docetaxel with prednisolone (DocP) to standard-of-care (SOC) each improved survival in STAMPEDE: a multi-arm multi-stage platform randomised controlled protocol recruiting patients with high-risk locally advanced or metastatic PCa starting long-term androgen deprivation therapy (ADT). The protocol provides the only direct, randomised comparative data of SOC+AAP vs SOC+DocP.
Citation
Sydes, M. R. et al. (2018) Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol. Annals of Oncology, 29(5), pp. 1235-1248.
Publisher
Journal
Research Unit
PubMed ID
29529169
PubMed Central ID
Embedded videos
Additional Links
Type
Journal article
Language
en
Description
Series/Report no.
ISSN
0923-7534